These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30679396)

  • 1. [Mineral metabolism and aging.].
    Kuro-O M
    Clin Calcium; 2019; 29(2):165-170. PubMed ID: 30679396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression.
    Kuro-O M
    Curr Opin Nephrol Hypertens; 2023 Jul; 32(4):344-351. PubMed ID: 37074676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity.
    Köppert S; Büscher A; Babler A; Ghallab A; Buhl EM; Latz E; Hengstler JG; Smith ER; Jahnen-Dechent W
    Front Immunol; 2018; 9():1991. PubMed ID: 30233585
    [No Abstract]   [Full Text] [Related]  

  • 4. Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage.
    Smith ER; Hanssen E; McMahon LP; Holt SG
    PLoS One; 2013; 8(4):e60904. PubMed ID: 23577176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease.
    Miura Y; Iwazu Y; Shiizaki K; Akimoto T; Kotani K; Kurabayashi M; Kurosu H; Kuro-O M
    Sci Rep; 2018 Jan; 8(1):1256. PubMed ID: 29352150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α.
    Aghagolzadeh P; Bachtler M; Bijarnia R; Jackson C; Smith ER; Odermatt A; Radpour R; Pasch A
    Atherosclerosis; 2016 Aug; 251():404-414. PubMed ID: 27289275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel assessments of systemic calcification propensity.
    Pasch A
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):278-84. PubMed ID: 27228365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD.
    Smith ER; Ford ML; Tomlinson LA; Rajkumar C; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2012 May; 27(5):1957-66. PubMed ID: 22105144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solving the insoluble: calciprotein particles mediate bulk mineral transport.
    Jahnen-Dechent W; Pasch A
    Kidney Int; 2023 Apr; 103(4):663-665. PubMed ID: 36948767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumenal calcification and microvasculopathy in fetuin-A-deficient mice lead to multiple organ morbidity.
    Herrmann M; Babler A; Moshkova I; Gremse F; Kiessling F; Kusebauch U; Nelea V; Kramann R; Moritz RL; McKee MD; Jahnen-Dechent W
    PLoS One; 2020; 15(2):e0228503. PubMed ID: 32074120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calciprotein particles: mineral behaving badly?
    Smith ER; Hewitson TD; Jahnen-Dechent W
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):378-386. PubMed ID: 32404635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease.
    Bruell S; Nicholls KM; Hewitson TD; Talbot AS; Holt SG; Smith ER; Ruderman I
    Osteoporos Int; 2022 Aug; 33(8):1783-1794. PubMed ID: 35575807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical transformation of calciprotein particles in uraemia.
    Smith ER; Hewitson TD; Hanssen E; Holt SG
    Bone; 2018 May; 110():355-367. PubMed ID: 29499417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetuin-A function in systemic mineral metabolism.
    Herrmann M; Kinkeldey A; Jahnen-Dechent W
    Trends Cardiovasc Med; 2012 Nov; 22(8):197-201. PubMed ID: 22902178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Klotho and calciprotein particles as therapeutic targets against accelerated ageing.
    Kuro-O M
    Clin Sci (Lond); 2021 Aug; 135(15):1915-1927. PubMed ID: 34374422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of calcifying nanoparticles in the etiology of multiple sclerosis.
    Can Demirdöğen B
    Med Hypotheses; 2019 Jul; 128():25-27. PubMed ID: 31203904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of Calciprotein Particles (CPPs) in Serum/Plasma Samples Using a Fluorescent Bisphosphonate.
    Miura Y; Kurosu H; Kuro-O M
    Methods Mol Biol; 2023; 2664():333-341. PubMed ID: 37423998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily variability in serum levels of calciprotein particles and their association with mineral metabolism parameters: A cross-sectional pilot study.
    Yamada H; Kuro-O M; Ishikawa SE; Funazaki S; Kusaka I; Kakei M; Hara K
    Nephrology (Carlton); 2018 Mar; 23(3):226-230. PubMed ID: 28052525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).
    Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fetuin-A-containing calciprotein particles on posttranslational modifications of fetuin-A in HepG2 cells.
    Uedono H; Mori K; Ochi A; Nakatani S; Miki Y; Tsuda A; Morioka T; Nagata Y; Imanishi Y; Shoji T; Inaba M; Emoto M
    Sci Rep; 2021 Apr; 11(1):7486. PubMed ID: 33820929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.